Robyn Lim

820 total citations
12 papers, 206 citations indexed

About

Robyn Lim is a scholar working on Economics and Econometrics, Biomedical Engineering and Physiology. According to data from OpenAlex, Robyn Lim has authored 12 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 5 papers in Biomedical Engineering and 4 papers in Physiology. Recurrent topics in Robyn Lim's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Biomedical and Engineering Education (4 papers) and Biomedical Ethics and Regulation (3 papers). Robyn Lim is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Biomedical and Engineering Education (4 papers) and Biomedical Ethics and Regulation (3 papers). Robyn Lim collaborates with scholars based in Canada, United Kingdom and United States. Robyn Lim's co-authors include Sebastian Schneeweiß, Gigi Hirsch, John C. W. Lim, Carole Longson, Reiner Banken, L G Baird, Janet Woodcock, Finn Børlum Kristensen, Mark Trusheim and Sean Tunis and has published in prestigious journals such as Anesthesia & Analgesia, Clinical Pharmacology & Therapeutics and Biochemical Society Transactions.

In The Last Decade

Robyn Lim

12 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robyn Lim Canada 6 123 46 38 22 20 12 206
Gigi Hirsch United States 7 135 1.1× 43 0.9× 38 1.0× 37 1.7× 27 1.4× 15 268
Thorsten Vetter Netherlands 7 96 0.8× 65 1.4× 27 0.7× 21 1.0× 15 0.8× 13 321
Ken Getz United States 9 44 0.4× 20 0.4× 24 0.6× 84 3.8× 27 1.4× 20 234
Josep Torrent-Farnell Spain 6 164 1.3× 12 0.3× 29 0.8× 29 1.3× 15 0.8× 10 256
Scott Askin Switzerland 5 50 0.4× 23 0.5× 23 0.6× 76 3.5× 32 1.6× 5 287
Edward Abrahams United States 6 45 0.4× 14 0.3× 21 0.6× 50 2.3× 20 1.0× 12 319
Carole A. Federico Canada 11 56 0.5× 9 0.2× 56 1.5× 76 3.5× 15 0.8× 20 324
Viktoriia Starokozhko Netherlands 12 65 0.5× 28 0.6× 25 0.7× 23 1.0× 5 0.3× 18 328
Gorana Capkun-Niggli Switzerland 9 87 0.7× 204 4.4× 130 3.4× 13 0.6× 8 0.4× 14 514
Nathalie Bere Netherlands 5 88 0.7× 24 0.5× 10 0.3× 17 0.8× 41 2.0× 8 158

Countries citing papers authored by Robyn Lim

Since Specialization
Citations

This map shows the geographic impact of Robyn Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn Lim more than expected).

Fields of papers citing papers by Robyn Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn Lim. The network helps show where Robyn Lim may publish in the future.

Co-authorship network of co-authors of Robyn Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Robyn Lim. A scholar is included among the top collaborators of Robyn Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robyn Lim. Robyn Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bonnen, Penelope E., Robyn Lim, John J. Mitchell, et al.. (2022). Rare diseases and space health: optimizing synergies from scientific questions to care. npj Microgravity. 8(1). 58–58. 3 indexed citations
2.
Lim, Robyn, John Ferguson, Marilyn Metcalf, et al.. (2018). Recognizing that Evidence is Made, not Born. Clinical Pharmacology & Therapeutics. 105(4). 844–856. 2 indexed citations
3.
Lim, Robyn, et al.. (2016). Regulatory Decision Making in Canada—Exploring New Frontiers in Patient Involvement. Value in Health. 19(6). 730–733. 14 indexed citations
4.
Bloechl‐Daum, Brigitte, Frank Bretz, Jeffrey S. Brown, et al.. (2016). “Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?. Clinical Pharmacology & Therapeutics. 100(6). 699–712. 57 indexed citations
5.
Hirsch, Gigi, Mark Trusheim, M Bala, et al.. (2016). Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need. Clinical Pharmacology & Therapeutics. 100(6). 685–698. 9 indexed citations
6.
Schneeweiß, Sebastian, Anna García‐Altés, S Garner, et al.. (2016). Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision‐Making. Clinical Pharmacology & Therapeutics. 100(6). 633–646. 44 indexed citations
7.
Baird, L G, Reiner Banken, Finn Børlum Kristensen, et al.. (2014). Accelerated Access to Innovative Medicines for Patients in Need. Clinical Pharmacology & Therapeutics. 96(5). 559–571. 64 indexed citations
8.
Trusheim, Mark, Lynn G. Baird, Sarah Garner, et al.. (2014). The Janus initiative: A multi-stakeholder process and tool set for facilitating and quantifying Adaptive Licensing discussions. Health Policy and Technology. 3(4). 241–247. 6 indexed citations
9.
10.
Teoh, Wendy H., et al.. (2004). Early diet resumption following caesarean delivery under regional anaesthesia: Safety and efficacy issues. Regional Anesthesia & Pain Medicine. 29. 33–33. 1 indexed citations
11.
Lim, Robyn. (2003). Rapacuronium: Premarket Drug Evaluation Can Be Very Effective for the Identification of Drug Risks. Anesthesia & Analgesia. 96(2). 631–632. 1 indexed citations
12.
Lim, Robyn, M. Bloomfield, Aaron M. Johnson, & Janet M. Allen. (1995). DOPAMINE CONCENTRATIONS IN PC12 CELLS FOLLOWING NEURONAL DIFFERENTIATION INDUCED BY NGF OR VIP. Biochemical Society Transactions. 23(1). 46S–46S. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gigi Hirsch Breakdown of academic impact, for papers by Thorsten Vetter Breakdown of academic impact, for papers by Ken Getz Breakdown of academic impact, for papers by Josep Torrent-Farnell Breakdown of academic impact, for papers by Scott Askin Breakdown of academic impact, for papers by Edward Abrahams Breakdown of academic impact, for papers by Carole A. Federico Breakdown of academic impact, for papers by Viktoriia Starokozhko Breakdown of academic impact, for papers by Gorana Capkun-Niggli Breakdown of academic impact, for papers by Nathalie Bere
Rankless by CCL
2026